{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:32:06Z","timestamp":1793727126406,"version":"4.6.1"},"reference-count":163,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001692","name":"Croucher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-169042"],"award-info":[{"award-number":["PJT-169042"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016977","name":"Peterborough K. M. Hunter Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000096","name":"Scottish Rite Charitable Foundation of Canada","doi-asserted-by":"publisher","award":["18119"],"award-info":[{"award-number":["18119"]}],"id":[{"id":"10.13039\/501100000096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmb.2023.168011","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T20:58:53Z","timestamp":1676321933000},"page":"168011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["\u03b1-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases"],"prefix":"10.1016","volume":"435","author":[{"given":"Raphaella W.L.","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel C.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2023.168011_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1084\/jem.20120741","article-title":"Prion-like spread of protein aggregates in neurodegeneration","volume":"209","author":"Polymenidou","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2023.168011_b0015","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The Synucleinopathies: Twenty Years On","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-020-02201-2","article-title":"The existence of Abeta strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease","volume":"142","author":"Lau","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmb.2023.168011_b0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-022-02426-3","article-title":"Ultrastructural and biochemical classification of pathogenic tau, alpha-synuclein and TDP-43","volume":"143","author":"Tarutani","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","article-title":"Evidence of distinct alpha-synuclein strains underlying disease heterogeneity","volume":"142","author":"Holec","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","article-title":"Tau strains shape disease","volume":"142","author":"Vaquer-Alicea","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00401-020-02222-x","article-title":"Phenotypic diversity in ALS and the role of poly-conformational protein misfolding","volume":"142","author":"Ayers","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0050","article-title":"Prion strains: shining new light on old concepts","author":"Block","year":"2022","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jmb.2023.168011_b0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41583-022-00603-7","article-title":"Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases","volume":"23","author":"Li","year":"2022","journal-title":"Nature Rev. Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","article-title":"Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies","volume":"109","author":"Peng","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0065","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0070","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0075","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0080","article-title":"The synucleins","volume":"3","author":"George","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mds.28941","article-title":"Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers","volume":"37","author":"Barba","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168011_b0090","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"alpha-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0095","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature12125","article-title":"Properties of native brain alpha-synuclein","volume":"498","author":"Burre","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168011_b0110","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0115","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human alpha-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nature Cell Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0125","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0130","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration","volume":"123","author":"Chandra","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168011_b0140","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0145","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bi4002369","article-title":"alpha-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers","volume":"52","author":"DeWitt","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2023.168011_b0150","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","article-title":"alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling","volume":"24","author":"Wang","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.774650","article-title":"Synuclein Regulates Synaptic Vesicle Clustering and Docking at a Vertebrate Synapse","volume":"9","author":"Fouke","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168011_b0165","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.0406283101","article-title":"Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions","volume":"101","author":"Chandra","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0170","doi-asserted-by":"crossref","first-page":"19573","DOI":"10.1073\/pnas.1005005107","article-title":"alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction","volume":"107","author":"Greten-Harrison","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0175","article-title":"Functional and Pathological Effects of alpha-Synuclein on Synaptic SNARE Complexes","volume":"167714","author":"Gao","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0180","series-title":"An essay on the shaking palsy","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.jmb.2023.168011_b0185","series-title":"Handbuch der Neurologie, Dritter Band, Spezielle Neurologie I","first-page":"920","article-title":"Paralysis agitans. I. Pathologische Anatomie","author":"Lewy","year":"1912"},{"key":"10.1016\/j.jmb.2023.168011_b0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2183\/pjab.90.301","article-title":"Lewy body disease and dementia with Lewy bodies","volume":"90","author":"Kosaka","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.jmb.2023.168011_b0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00685366","article-title":"Presenile dementia with Alzheimer-, Pick- and Lewy-body changes","volume":"36","author":"Kosaka","year":"1976","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00690978","article-title":"Lewy bodies in cerebral cortex, report of three cases","volume":"42","author":"Kosaka","year":"1978","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1440-1789.1996.tb00152.x","article-title":"Cerebral type of Lewy body disease","volume":"16","author":"Kosaka","year":"1996","journal-title":"Neuropathology"},{"key":"10.1016\/j.jmb.2023.168011_b0210","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168011_b0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2023.168011_b0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F","article-title":"Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease","volume":"47","author":"Solano","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.52.Suppl.78","article-title":"Multiple system atrophy\u2013the nature of the beast","volume":"Suppl:","author":"Quinn","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jmb.2023.168011_b0235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168011_b0240","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00294235","article-title":"Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies","volume":"79","author":"Kato","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00005072-199009000-00007","article-title":"Oligodendroglial microtubular tangles in olivopontocerebellar atrophy","volume":"49","author":"Nakazato","year":"1990","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jmb.2023.168011_b0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0022-510X(92)90286-T","article-title":"Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy","volume":"107","author":"Papp","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jmb.2023.168011_b0260","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jmb.2023.168011_b0265","first-page":"839","article-title":"Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M","volume":"388","author":"Spillantini","year":"1997","journal-title":"Alpha-synuclein in Lewy bodies. Nature."},{"key":"10.1016\/j.jmb.2023.168011_b0270","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Letter"},{"key":"10.1016\/j.jmb.2023.168011_b0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1353-8020(99)00031-0","article-title":"Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies","volume":"5","author":"Spillantini","year":"1999","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168011_b0280","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","article-title":"Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia","volume":"112","author":"Miller","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jmb.2023.168011_b0285","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/glia.22653","article-title":"Alpha-synuclein mRNA expression in oligodendrocytes in MSA","volume":"62","author":"Asi","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jmb.2023.168011_b0290","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.410270309","article-title":"A large kindred with autosomal dominant Parkinson's disease","volume":"27","author":"Golbe","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nature Genet."},{"key":"10.1016\/j.jmb.2023.168011_b0300","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0305","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0310","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2023.168011_b0315","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0325","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","article-title":"A general model of prion strains and their pathogenicity","volume":"318","author":"Collinge","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0330","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm2204","article-title":"Insights into prion strains and neurotoxicity","volume":"8","author":"Aguzzi","year":"2007","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0335","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/acsbiomaterials.9b01302","article-title":"The Structural Basis of Amyloid Strains in Alzheimer\u2019s Disease","volume":"6","author":"Makowski","year":"2020","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jmb.2023.168011_b0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick's disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0350","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","article-title":"Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules","volume":"568","author":"Falcon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0355","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","article-title":"Structure of pathological TDP-43 filaments from ALS with FTLD","volume":"601","author":"Arseni","year":"2022","journal-title":"Nature"},{"issue":"4540\u201351","key":"10.1016\/j.jmb.2023.168011_b0365","first-page":"e6","article-title":"High-resolution structure and strain comparison of infectious mammalian prions","volume":"81","author":"Kraus","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2023.168011_b0370","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1038\/s41467-022-30457-7","article-title":"2.7 A cryo-EM structure of ex vivo RML prion fibrils","volume":"13","author":"Manka","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0375","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-022-02461-0","article-title":"Cryo-EM structures of prion protein filaments from Gerstmann-Straussler-Scheinker disease","volume":"144","author":"Hallinan","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0380","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0304-3940(00)01440-3","article-title":"Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain","volume":"292","author":"Crowther","year":"2000","journal-title":"Neurosci. Letter"},{"key":"10.1016\/j.jmb.2023.168011_b0385","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"a-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","article-title":"Potent prion-like behaviors of pathogenic alpha-synuclein and evaluation of inactivation methods","volume":"6","author":"Tarutani","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0395","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0400","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of alpha-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0405","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2023.168011_b0410","doi-asserted-by":"crossref","first-page":"eabc4364","DOI":"10.1126\/sciadv.abc4364","article-title":"Novel self-replicating alpha-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons","volume":"6","author":"De Giorgi","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jmb.2023.168011_b0415","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104712","article-title":"Characterization of novel conformation-selective alpha-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease","volume":"136","author":"Henderson","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0430","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/nan.12402","article-title":"Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease","volume":"43","author":"Covell","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jmb.2023.168011_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105086","volume":"146","author":"Kumar","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0440","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0445","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"alpha-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.jmb.2023.168011_b0450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez-Valbuena","year":"2022","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.jmb.2023.168011_b0455","doi-asserted-by":"crossref","first-page":"19105","DOI":"10.1073\/pnas.0608970103","article-title":"Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes","volume":"103","author":"Legname","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0460","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168011_b0465","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jnc.15147","article-title":"Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get","volume":"157","author":"Frey","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2023.168011_b0470","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jnc.15275","article-title":"Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model","volume":"157","author":"Lashuel","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2023.168011_b0475","doi-asserted-by":"crossref","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","article-title":"Propagation of prions causing synucleinopathies in cultured cells","volume":"112","author":"Woerman","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0480","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0485","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0490","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1074\/jbc.RA119.012179","article-title":"alpha-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species","volume":"295","author":"Morgan","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0495","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1073\/pnas.1719369115","article-title":"Familial Parkinson's point mutation abolishes multiple system atrophy prion replication","volume":"115","author":"Woerman","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0500","doi-asserted-by":"crossref","first-page":"e1010956","DOI":"10.1371\/journal.ppat.1010956","article-title":"The E46K mutation modulates alpha-synuclein prion replication in transgenic mice","volume":"18","author":"Holec","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2023.168011_b0505","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","article-title":"Consequences of variability in alpha-synuclein fibril structure on strain biology","volume":"143","author":"Holec","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0510","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113489119","article-title":"Different alpha-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy","volume":"119","author":"Ayers","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0515","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-019-01959-4","article-title":"Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines","volume":"137","author":"Woerman","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0520","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1074\/jbc.R114.550707","article-title":"Mouse models for studying the formation and propagation of prions","volume":"289","author":"Watts","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0525","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168011_b0530","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s40478-019-0804-5","article-title":"Silver staining (Campbell-Switzer) of neuronal alpha-synuclein assemblies induced by multiple system atrophy and Parkinson's disease brain extracts in transgenic mice","volume":"7","author":"Lavenir","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0540","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","article-title":"Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils","volume":"7","author":"Dhillon","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0545","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-022-02425-4","article-title":"Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice","volume":"143","author":"Lloyd","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0550","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-017-1762-2","article-title":"MSA prions exhibit remarkable stability and resistance to inactivation","volume":"135","author":"Woerman","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0555","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-021-02312-4","article-title":"Transmissible alpha-synuclein seeding activity in brain and stomach of patients with Parkinson's disease","volume":"141","author":"Thomzig","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0560","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00401-022-02476-7","article-title":"Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human alpha-synuclein","volume":"144","author":"Holec","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0565","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","article-title":"Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein","volume":"3","author":"Bernis","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0570","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jnen\/nlz070","article-title":"Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (alpha-Syn) Pathology in Synthetic alpha-Syn Fibril-Induced Mouse Models of Synucleinopathy","volume":"78","author":"Uemura","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0575","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","article-title":"Alpha-synuclein transfers from neurons to oligodendrocytes","volume":"62","author":"Reyes","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jmb.2023.168011_b0580","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0585","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson's disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168011_b0590","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a Biochemical Diagnosis of Parkinson Disease by Detection of alpha-Synuclein Misfolded Aggregates in Cerebrospinal Fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0595","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0600","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25824","article-title":"Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies","volume":"88","author":"Singer","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0605","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1038\/s41467-021-23682-z","article-title":"Phenotypic manifestation of alpha-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons","volume":"12","author":"Tanudjojo","year":"2021","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0610","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ana.25446","article-title":"Seeding variability of different alpha synuclein strains in synucleinopathies","volume":"85","author":"Candelise","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168011_b0615","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct alpha-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168011_b0625","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Strohaker","year":"2019","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0630","doi-asserted-by":"crossref","unstructured":"Sokratian A, Zhou Y, Xu E, Viverette E, Dillard L, Yuan Y, et al. Structural and functional landscape of \u03b1-synuclein fibril conformations amplified from cerebrospinal fluid. bioRxiv. 2022:2022.07.13.499896.","DOI":"10.21203\/rs.3.rs-1832778\/v1"},{"key":"10.1016\/j.jmb.2023.168011_b0635","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s42003-022-03948-y","article-title":"Quaternary structure of patient-homogenate amplified alpha-synuclein fibrils modulates seeding of endogenous alpha-synuclein","volume":"5","author":"Frieg","year":"2022","journal-title":"Commun Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0640","doi-asserted-by":"crossref","first-page":"e48907","DOI":"10.7554\/eLife.48907","article-title":"Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy","volume":"8","author":"Guerrero-Ferreira","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168011_b0645","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/2211-5463.13110","article-title":"Seeded assembly in vitro does not replicate the structures of alpha-synuclein filaments from multiple system atrophy","volume":"11","author":"Lovestam","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jmb.2023.168011_b0650","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jmb.2023.168011_b0655","doi-asserted-by":"crossref","first-page":"e56825","DOI":"10.7554\/eLife.56825","article-title":"alpha-synuclein strains that cause distinct pathologies differentially inhibit proteasome","volume":"9","author":"Suzuki","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168011_b0660","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168011_b0665","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/brain\/awac061","article-title":"Host oligodendrogliopathy and alpha-synuclein strains dictate disease severity in multiple system atrophy","volume":"146","author":"Torre-Muruzabal","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168011_b0670","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s40478-019-0859-3","article-title":"alpha-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb","volume":"7","author":"Rey","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0675","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bpj.2020.01.022","article-title":"Differential Membrane Binding and Seeding of Distinct alpha-Synuclein Fibrillar Polymorphs","volume":"118","author":"Shrivastava","year":"2020","journal-title":"Biophys. J ."},{"key":"10.1016\/j.jmb.2023.168011_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100737","article-title":"The differential solvent exposure of N-terminal residues provides \u201cfingerprints\u201d of alpha-synuclein fibrillar polymorphs","volume":"296","author":"Landureau","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0685","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-021-00242-5","article-title":"Differential seeding and propagating efficiency of alpha-synuclein strains generated in different conditions","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.jmb.2023.168011_b0690","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1038\/s41598-022-15472-4","article-title":"Bivalent metal ions induce formation of alpha-synuclein fibril polymorphs with different cytotoxicities","volume":"12","author":"Atarod","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2023.168011_b0695","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41467-022-31790-7","article-title":"Heparin induces alpha-synuclein to form new fibril polymorphs with attenuated neuropathology","volume":"13","author":"Tao","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0700","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1074\/jbc.RA118.004267","article-title":"Glycosaminoglycans have variable effects on alpha-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils","volume":"293","author":"Mehra","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0705","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-021-02316-0","article-title":"Multiple system atrophy-associated oligodendroglial protein p25alpha stimulates formation of novel alpha-synuclein strain with enhanced neurodegenerative potential","volume":"142","author":"Ferreira","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168011_b0710","doi-asserted-by":"crossref","first-page":"37130","DOI":"10.1038\/srep37130","article-title":"Phosphorylation induces distinct alpha-synuclein strain formation","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2023.168011_b0715","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/biom12030436","article-title":"Neurons with Cat\u2019s Eyes: A Synthetic Strain of alpha-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions","volume":"12","author":"De Giorgi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmb.2023.168011_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167761","article-title":"alpha-Synuclein Aggregation Intermediates form Fibril Polymorphs with Distinct Prion-like Properties","volume":"434","author":"Mehra","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0725","doi-asserted-by":"crossref","first-page":"e76494","DOI":"10.7554\/eLife.76494","article-title":"Assembly of recombinant tau into filaments identical to those of Alzheimer\u2019s disease and chronic traumatic encephalopathy","volume":"11","author":"Lovestam","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168011_b0730","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nature Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0735","doi-asserted-by":"crossref","first-page":"e36402","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168011_b0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jmb.2012.04.009","article-title":"Structural comparison of mouse and human alpha-synuclein amyloid fibrils by solid-state NMR","volume":"420","author":"Lv","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168011_b0745","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12104-015-9628-9","article-title":"Further exploration of the conformational space of alpha-synuclein fibrils: solid-state NMR assignment of a high-pH polymorph","volume":"10","author":"Verasdonck","year":"2016","journal-title":"Biomol. NMR Assign."},{"key":"10.1016\/j.jmb.2023.168011_b0750","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length alpha-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0755","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1074\/jbc.M115.698787","article-title":"alpha-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils","volume":"291","author":"Dearborn","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0760","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40478-021-01288-2","article-title":"Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro","volume":"9","author":"Marotta","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168011_b0765","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","article-title":"The Effect of Fragmented Pathogenic alpha-Synuclein Seeds on Prion-like Propagation","volume":"291","author":"Tarutani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168011_b0770","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2023.168011_b0775","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","article-title":"Prion-like acceleration of a synucleinopathy in a transgenic mouse model","volume":"33","author":"Mougenot","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2023.168011_b0780","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1126\/science.1190815","article-title":"Medicine. Prion strain mutation and selection","volume":"328","author":"Collinge","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0785","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1183218","article-title":"Darwinian evolution of prions in cell culture","volume":"327","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168011_b0790","doi-asserted-by":"crossref","first-page":"E4160","DOI":"10.1073\/pnas.1317164110","article-title":"Drug resistance confounding prion therapeutics","volume":"110","author":"Berry","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168011_b0795","doi-asserted-by":"crossref","first-page":"e1003759","DOI":"10.1371\/journal.ppat.1003759","article-title":"The evolution of transmissible prions: the role of deformed templating","volume":"9","author":"Makarava","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2023.168011_b0800","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.pmbts.2020.07.009","article-title":"Cofactor molecules: Essential partners for infectious prions","volume":"175","author":"Supattapone","year":"2020","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jmb.2023.168011_b0805","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/brain\/awab440","article-title":"Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns","volume":"145","author":"Rahayel","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168011_b0810","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1128\/JVI.00243-10","article-title":"Coinfecting prion strains compete for a limiting cellular resource","volume":"84","author":"Shikiya","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2023.168011_b0815","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00401-019-02058-0","article-title":"Calling alpha-synuclein a prion is scientifically justifiable","volume":"138","author":"Watts","year":"2019","journal-title":"Acta Neuropathol."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:27:47Z","timestamp":1762669667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283623000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":163,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0022283623000670"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168011","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"168011"}}